Skip to content
DefDex

Federal award

STICHTING PHARMACCESS INTERNATIONAL

W81XWH1210145

Assistance

Obligated and Ceiling

Obligated (net)
$38,227,662.00
Potential value
—
Current value
—
Gross positive obligations
$38,394,360.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
STICHTING PHARMACCESS INTERNATIONAL · ETM7KNKPSL44
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
—
Awarding agency
Department of Defense · sub-agency 2100 · office W81XWH
Funding agency
Department of Defense · sub-agency 2100
Assistance listing (CFDA)
CFDA 12.420
FAIN
W81XWH1210145
Award type code
04
Actions
15 · May 2, 2012 to Apr 22, 2020
Why it is listed
a program on the reviewed research-assistance allowlist (DoD, DOE or NASA from $10k, or eligible DHS research)

Open this award on USAspending →

Action History15

Award actions
DateFYModAction typeObligationCompany in company totals
Apr 22, 2020FY2020P00015FX−$166,698.00
—
Sep 21, 2018FY2018P00014B1$1,784,186.00
—
Mar 28, 2018FY2018P00013EX$1,928,913.00
—
Jul 17, 2017FY2017P00012EX$4,239,792.00
—
Sep 19, 2016FY20160011B1$527,356.00
—
Jul 21, 2016FY20160010B1$3,502,253.00
—
Sep 1, 2015FY20150008B1$2,288,354.00
—
Feb 11, 2015FY20150007B1$2,698,128.00
—
Aug 28, 2014FY20140006B1$2,228,154.00
—
Mar 27, 2014FY20140004B1$2,168,994.00
—
Jan 7, 2014FY20140003B1$450,000.00
—
Mar 26, 2013FY20130002B1$4,278,830.00
—
May 2, 2012FY2012—A1$4,099,800.00
—
May 2, 2012FY2012—A1$4,099,800.00
—
May 2, 2012FY2012000000A1$4,099,800.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.